MAPK9 and cancer: Although the detailed mechanism by which JNK2 activates PHD1 remains unclear, our findings collectively demonstrate that docetaxel induces cell death in cancer cells under hypoxic conditions by activating the JNK2/PHD1 signaling pathway (Fig. 6i).